Company / Interest Expense per Share
RHYTHM PHARMACEUTICALS, INC. Interest Expense per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.25
FY2023
5-year range
$0.10 / $0.25
FY2022-FY2023
Trend
+145.9%
vs FY2022
Sector context
#18 of 43
Health Care
What the data says
At $0.25, RHYTHM PHARMACEUTICALS, INC.'s interest expense per share ranks #26 of 43 in the Health Care sector.
Based on SEC 10-K filings.
0.25 in FY2023.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#26 of 43 in Health CareTop 58% of 43This company $0.25 Sector average $18.61
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 145.9% year-over-year.
- Ranks #18 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.25 | +145.9% |
| FY2022 | $0.10 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026